Navigation Links
Ancor and Merit acquire Uplift Technologies for Carex Health Brands
Date:7/10/2012

FORT WORTH, Texas, July 10, 2012 /PRNewswire/ --  Ancor Capital Partners and Merit Capital Partners announced the acquisition of Canada-based Uplift Technologies, a leader in the development, manufacturing and sales of seat-assist and light-therapy medical products. With the acquisition, Uplift Technologies will operate through Carex Health Brands Canada, a division of Boston-based Carex Health Brands.  Founded in 1993 in Dartmouth, Nova Scotia, Canada, Uplift Technologies offers clinically proven and patented seat-assist and light-therapy products with its Uplift and Daylight brands.

"This marks our second acquisition in the past year for Carex," said J. Randall Keene, Partner with Ancor and Director of Carex. "Ancor teamed up with Merit Capital approximately two years ago to acquire Carex Health Brands, and our vision was to build the company through both internal growth and acquisitions."

According to Keene, Ancor previously acquired Detach N' Go and its product line of Detachable Pill Cases are now marketed through Carex.

"The acquisition of Uplift is a meaningful step in establishing Carex as the leader in home medical products distributed through retail distribution channels," said Terrance M. Shipp, Managing Director at Merit Capital.

Carex will add the Uplift seat-assist and light-therapy brands to its product lines which include Carex, Apex, Bed Buddy, Thera-Med and Detach N' Go.

"We were impressed with the innovative nature of the Uplift Technologies products," said Matt McElduff, President of Carex.  "The Uplift seat-assist and light-therapy products are an obvious extension of our category-leading Carex brand. We expect to have an immediate impact on sales by leveraging our extensive sales and logistics network. And we will add their existing products to our current broad base of distribution, while continuing to innovate and expand the Uplift categories under the Carex brand."

According to McElduff, the brands marketed by Carex have achieved broad customer awareness in the marketplace and are used by home-care patients, the mobility challenged, senior citizens and members of the general public. Carex is the market leader in branded home-medical equipment sold through drug store chains, mass merchants, DME dealers, grocery retailers and online retailers. In addition, Carex offers one of the broadest product lines in hot/cold pain therapy and medication compliance aids. Carex products also are fully stocked with drug wholesalers who service this retail market.

Ancor Capital Partners, based in Fort Worth, Texas, is an operations-oriented private equity firm focused on lower middle-market manufacturing and distribution companies with EBITDA of $5-$15 million.  Extensive operational experience gives the Ancor team a unique understanding of the critical business issues faced by lower middle-market companies.  Ancor's proven track record includes 30 acquisitions to date in health care, consumer and other industries.Contact:

Brook M. Smith, Managing DirectorAncor Capital817-509-5242bsmith@ancorcapital.com


'/>"/>
SOURCE Ancor Capital Partners
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Ameritox Files Amended Complaint Against Millennium Laboratories For Injunctive Relief, Declaratory Relief and Damages
2. Ameritox Announces Educational Resources to Help Physicians Navigate Complex Compliance Issues
3. Millennium Laboratories Wins Lawsuit: Ameritox Advertisements Regarding Rx Guardian and Rx Guardian CD Contain Literally False Statements
4. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
5. Watson to Acquire Actavis Group for EUR4.25 Billion
6. VWR International, LLC Signs Agreement to Acquire basan Germany GmbH
7. Haemonetics Signs Definitive Agreement To Acquire Hemerus Medical, LLC
8. Haemonetics Signs Definitive Agreement to Acquire Pall Corporations Blood Collection, Filtration and Processing Product Lines For $551 Million
9. Kensey Nash Agrees to Be Acquired by DSM for $38.50 per Share in Cash
10. Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
11. Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... CAMBRIDGE , United Kingdom and  BOSTON ... text analytics provider Linguamatics today announced ... Dow Jones . The agreement allows pharmaceutical companies ... utilizing Linguamatics I2E text mining technology. ... used by 18 of the top 20 global ...
(Date:3/28/2017)... 28, 2017  AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ... and commercialization of innovative therapies for the treatment ... Medicines Agency (EMA) has notified the company that ... Authorisation Application (MAA) has passed validation, and that ... The MAA for ARX-04 (known as DSUVIA™ in ...
(Date:3/28/2017)... -- The global flow cytometry market ... 2025, according to a new study by Grand View ... cancer is expected to upsurge the demand for flow ... years. In addition, higher number of physicians is inclined ... therapy, due to adverse effects caused by chemotherapy & ...
Breaking Medicine Technology:
(Date:3/28/2017)... , ... March 28, 2017 , ... Usually, the impending ... daily wardrobe. However, for those self-conscious about a double chin, this means more anxiety ... ideal solution. , “For most people, a double chin is undesirable,” Dr. Goldman ...
(Date:3/28/2017)... ... March 28, 2017 , ... Qualidigm ... its corporate headquarters to a new, more expansive office space in order to ... Qualidigm purchased a distressed office building in Wethersfield, Conn. located at 936 Silas ...
(Date:3/28/2017)... ... March 28, 2017 , ... In ... Self-Funding Success website has recently developed and published an informational resource that addresses ... created based on common inquiries the site’s team of third party administrator (TPA) ...
(Date:3/28/2017)... ... 28, 2017 , ... AutismOne announced the Board Certified in ... Medicine and available for application on Saturday, May 27, 2017, following Thursday, Friday, ... Springs. , Ed Arranga, president of AutismOne, stated: "Many of the modalities termed ...
(Date:3/28/2017)... , ... March 28, 2017 , ... With expansion and ... Georgia, in early March. , The seed processing plant opened in Marshallville in 2006, ... 2016. The new office allows opportunity for transition of Patten Seed operations to the ...
Breaking Medicine News(10 mins):